Crystalline forms of 3-(1-(( 1 r,4r,5s)-2-azabicyclo[2.1.1] hexan-5-yl)-2-(( 1 r,3r,5r)-2-( cyclopropanecarbonyl)-2- azabicyclo[3.1.0]hexan-3-yl)-7-(2,3-dichlorophenyl)-6-fluoro-4-methyl-1 h-pyrrolo[3,2-c]quinolin-8-yl)propanenitrile
GEAP202616971APending Publication Date: 2026-08-25INCYTE CORP
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- GEAP202616971P0
- Authority / Receiving Office
- GE · GE
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-24
- Filing Date
- 2024-10-08
- Publication Date
- 2026-08-25
Abstract
INCY0500-WO1 / / 758397: ICT-500PC ABSTRACT This disclosure provides salts, crystalline forms, and formulations of a KRAS inhibitor, and methods of making and using thereof. 66
Need to check novelty before this filing date? Find Prior Art